Defined by the National Cancer Institute, clinical trials in supportive or palliative care explore ways to improve the comfort and quality of life of cancer patients and cancer survivors.
The trials conducted in the Department of Palliative, Rehabilitation and Integrative Medicine identify ways to help people who are experiencing symptoms related to cancer and its treatment, such as fatigue, nausea, pain, weight loss, sleep disorders, and depression. Some supportive care trials also look at nutrition, rehabilitation and other interventions that aim to benefit patients and survivors.
Current clinical trials
- Effects of Anamorelin on Cancer-Related Fatigue
- Methylphenidate for Cancer-Related Fatigue
- Exercise + Dexamethasone for Cancer-related Fatigue
- Dexamethasone and Physical Activity for Cancer-Related Fatigue
- Randomized Controlled Trial of Dexamethasone for Dyspnea
- Haloperidol and/or Chlorpromazine for Agitated Delirium
- Netupitant and Palonosetron (NEPA) for Chronic Nausea and Vomiting
- Use of Macy Catheter for Rectal Administration of Opioids
- High-Flow Oxygen for Exertional Dyspnea
- Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea
- Survey of Rehabilitation Safety Concerns after Discharge
- Preparing Patients and Family Caregivers for Medical Decision Making
- Dignity Therapy for the Elderly Patient
- Patient Experience on the Effects of Standardized Supportive Care Consultation
Frequencyof Chronic Non-Malignant Pain among Supportive Care Consult Patients
- Randomized Controlled Trial of Informational Materials to help facilitate physician-patient communication
- Barriers Affecting Physical Activity
- Use of Prognostic Website in Estimating Survival (For Physicians Only)
- A Survey of Parent/Caregiver Practices on the Storage, Use, and Disposal of Opioids
For more information about ongoing, active, supportive care trials in the Department of Palliative, Rehabilitation & Integrative Medicine, contact Lilian Larsson, 713-745-9025; or Julio Allo, 713-563-1806.